Pre-Approval Information Exchange (PIE) Sessions

What is a PIE Session?

It’s an opportunity for pharmaceutical companies to share clinical and access information on medications awaiting approval through Pre-Approval Information Exchange (PIE) with pharmacists who meet the criteria of Health Care Decision Makers (HCDMs). The focus of these exchanges is to provide HCDMs with critical data for proactive planning on new cancer drugs before market approval.

These events occur in conjunction with the **ATOPP Summit. There are two types of PIE Sessions: Live and Virtual.**

ATOPP Virtual PIE Sessions

Two virtual events taking place after the ATOPP Summit:

Clinical Updates in DLBCL: FrontMIND Study & First-Line Tafasitamab Data

Hosted by: Incyte:
August 19, 2:00 – 3:00pm ET
Register here on ZOOM

Advanced ALK+ NSCLC Unmet Needs andNeladalkib Clinical Evidence from ALKOVE-1

Hosted by: Nuvalent:
September 16, 2:00 – 3:00pm ET
Register here on ZOOM

ATOPP Live PIE Sessions

Four live events taking place at ATOPP Summit:

Trodelvy in First Line Metastatic Triple Negative Breast Cancer
Hosted by: Gilead

When: Friday, July 17, 10:45 – 11:30am ET
Where: Riverview Ballroom 1 at the Gaylord National Resort

Daraxonrasib Investigational Oral RAS(ON) Multi-Selective Inhibitor
Hosted by: Revolution Medicines

When: Friday, July 17, 10:45 – 11:30am ET
Where: Riverview Ballroom 2 at the Gaylord National Resort

Ifinatamab Deruxtecan (I-DXd): IDeate-Lung01
Hosted by: Daiichi Sankyo

When: Friday, July 17, 2:00 – 2:45pm ET
Where: Riverview Ballroom 1 at the Gaylord National Resort

Amivantamab SC for the Treatment of Patients With R/M HNSCC Who Have Received Platinum-Based Chemotherapy and a PD -L1 Inhibitor
Hosted by: Johnson & Johnson

When: Friday, July 17, 2:00 – 2:45pm ET
Where: Riverview Ballroom 2 at the Gaylord National Resort

Register here!

FOR INDUSTRY

Are you hosting a PIE Session?



Hear from Dave Hughes, Senior Medical Director – Hematology at Pfizer, on what a PIE session is and the value from an industry perspective, as a pharmaceutical company hosting the event:

Registration to host a PIE session is closed for ATOPP!

FOR HCDMs

Are you wanting to attend a PIE Session?



Hear from Kristen Boykin, Director of Pharmacy Operations at Florida Cancer Specialists & Research Institute, on what to expect at a PIE Session as a Health Care Decision Maker (HCDM):

What is a HCDM?

You may be a HCDM if you are a:

Member of a formulary committee OR provide information to a committee that selects drugs to include on formulary or within treatment pathways (eg, P&T committee)
Member of a committee OR provide information to a committee that makes decisions regarding drug selection, formulary inclusion, coverage, reimbursement, clinical pathways, healthcare quality, patient outcomes, or contracting for health care organizations (e.g., integrated delivery networks, hospitals, health systems, GPOs).
Formulary decision maker for a payer by providing information for the purpose of making formulary decisions.

Pharmaceutical companies will conduct four concurrent 45-minute PIE sessions in private rooms, exclusively for pharmacist attendees meeting the sponsor’s HCDM criteria.

No employees from a competing pharmaceutical company are permitted to attend PIE sessions. A networking refreshment break will be available at this time for anyone who is not permitted to attend the PIE sessions.